TrialThe oncologist2024

A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial.

Marie S Dreyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.